Stocktoria
VASO Corp VASO
OTC · OOTC · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1988-12-01
VASO Corp financials (annual, from 10-K)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $89.1M | $86.8M | $81.0M | $79.3M | $75.6M | $69.8M | $75.5M | $74.0M | $72.8M | $72.6M |
| Gross profit | $54.7M | $52.0M | $50.6M | $47.9M | $43.1M | $38.6M | $42.4M | $41.1M | $40.7M | $41.5M |
| R&D expense | $728,000 | $851,000 | $755,000 | $605,000 | $1.7M | $745,000 | $813,000 | $886,000 | $945,000 | $530,000 |
| SG&A expense | $52.2M | $49.0M | $45.1M | $40.8M | $38.6M | $37.1M | $41.0M | $44.0M | $43.6M | $39.4M |
| Operating income | -$2.9M | $285,000 | $4.2M | $6.5M | $2.8M | $772,000 | $591,000 | -$3.7M | -$3.8M | $1.6M |
| Income tax | -$2.9M | $326,000 | $100,000 | -$4.7M | $151,000 | $1,000 | $111,000 | -$385,000 | $134,000 | $281,000 |
| Net income | $1.6M | $951,000 | $4.8M | $11.3M | $6.1M | $358,000 | -$382,000 | -$3.7M | -$4.5M | $820,000 |
| EPS (diluted) | $0.01 | $0.01 | $0.03 | $0.06 | — | $0.00 | $0.00 | $-0.02 | — | — |
| Operating cash flow | $9.3M | $3.3M | $5.3M | $14.4M | $7.8M | $5.9M | -$1.3M | -$1.5M | $1.6M | $5.2M |
| Free cash flow | — | — | — | $13.8M | $7.4M | $4.9M | -$2.5M | -$4.0M | -$775,000 | $3.3M |
| Cash & equivalents | $35.0M | $26.3M | $11.3M | $11.8M | $6.0M | $6.8M | $2.1M | $2.7M | $5.2M | $7.1M |
| Inventory | $833,000 | $911,000 | $1.5M | $1.5M | $1.1M | $1.4M | $1.9M | $2.0M | $2.4M | $2.4M |
| Total assets | $88.3M | $82.9M | $75.8M | $71.6M | $52.4M | $50.4M | $54.4M | $50.5M | $56.8M | $57.4M |
| Shareholders' equity | $29.4M | $27.7M | $26.8M | $22.1M | $11.3M | $5.1M | $4.3M | $4.6M | $9.2M | $12.9M |
Growth · year-over-year · Revenue CAGR 2.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.7% | +7.1% | +2.2% | +4.9% | +8.2% | -7.5% | +2.1% | +1.6% | +0.3% | +27.2% |
| Net income growth | +65.0% | -80.2% | -57.5% | +85.1% | +1603.9% | — | — | — | -653.5% | -78.6% |
| EPS growth | +0.0% | -66.7% | -50.0% | — | — | — | — | — | — | — |
| Free cash flow growth | — | — | — | +87.2% | +50.0% | — | — | — | -123.1% | -40.5% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000839087 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.